NDC 72162-2565 – Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate

Efavirenz 600 mg/1; Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC72162-2565

Product details

Brand name
Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate
Generic name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203041
Marketed since
March 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Efavirenz, emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
72162-2565-330 TABLET, FILM COATED in 1 BOTTLE (72162-2565-3)Nov 4, 2025

Other Efavirenz, emtricitabine and tenofovir disoproxil fumarate products